Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Anheuser-Busch InBev

Canopy Growth

Cronos Group

Heineken NV

HEXO Corp

Constellation Brands

Molson Coors Brewing

Tilray Brands

Just because you can doesn't mean you should.

Maybe These Beverage Giants Should Have Stayed Away From Cannabis Drinks

British American Tobacco

GlaxoSmithKline

Pfizer

Starwood Property

Cohen & Steers Infrastructure Fund Inc

After 16 weeks and $1,700, the Dividend Harvesting Portfolio is generating $108.72 in estimated annual income and $9.06 in monthly estimated income. I started a position in British Tobacco p.l.c and added to my current positions of Starwood Property Trust and Cohen&Steers Infrastructure Fund.

Dividend Harvesting: Week 17 Update, Building The Portfolio Brick By Brick

Philip Morris

Benzinga's weekly Stock Wars matches up two leaders in a major industry sector, with the goal of allowing readers to decide which company is the better investment. This week, the duel is between two tobacco industry titans: Altria Group Inc. (NYSE: MO) and Philip Morris International Inc. (NYSE: PM).

Stock Wars: Altria Group Vs. Philip Morris International

Enbridge

Doubling your investment in five years is the goal of many investors. Even in this 33% overvalued market, you can still double your money in five years, and with the highest quality blue-chips, even high-yield dividend aristocrats.

3 High-Yield Dividend Aristocrats That Could Double In The Next 5 Years

Alphabet

Lockheed Martin

ViacomCBS

Verizon

In the first part of this article, I explain that there are absolutely bubble feelings and vibes, but that not everything is properly priced. Then in the second part, I provide some pretty clear evidence that there are some good reasons for equities to be trading higher right now.

Still No Bubble: 3 Picks For This Raging Bull Market

Canadian Natural Resources

Caesarstone

Enterprise Products Partners

Energy Transfer LP Unit

FS KKR Capital Corp

Hercules Capital

Imperial Brands PLC

Coca-Cola Femsa SAB de CV

OneMain Hld

Sibanye Stillwater

AT&T

Ternium

May 14-June 23, 2021 readers mentioned 48 equities in their comments. Some lamented bad news, so bad news investments (rogues) mixed with (mostly) favorites. (Hence, these are the ReFa/Ro). Ten analyst target estimated TOP NET GAIN reader faves & rogues (ReFa/Ro) MO, CNQ, EPD, KOF, ET, CSTE, BTI, TX, SBSW, & IMBBY averaged 44.91% net gains from data collected 6/23/21.

48 Reader Favorites And Rogues 5/14/21-6/23/21 Feature 27 Ideal Dividend Dogs, Ready To Adopt

AbbVie

The advantages these companies bring to the table makes their payouts reliable. That makes them excellent dividend stocks to buy.

3 High-Yield Stocks With Secure Payouts

Home Depot

Mastercard

Progressive

Raytheon Technologies

While the excitement in the market remains centered on meme trades, these overlooked blue-chip stocks offer much-needed stability. The post 7 Overlooked Blue-Chip Stocks to Buy for Eagle-Eyed Investors appeared first on InvestorPlace.

7 Overlooked Blue-Chip Stocks to Buy for Eagle-Eyed Investors

Altria is one of the Dividend Kings' highest-conviction recommendations. It's still in a bear market. Yet it's offered impressive returns.

Altria Is Up 69% But Set To Soar So Much More

American Express

AcelRx Pharmaceuticals

Alexandria Real Estate Equities

Spero Therapeutics

Q.ai runs daily factor models to get the most up-to-date reading on stocks and ETFs. Today, our deep-learning algorithms have identified American Express Company among others.

American Express Company Ranked Among Today's Trending Stocks

Global X SuperDividend Alternatives ETF

Alerian MLP ETF

Bristol-Myers

Cisco Systems

Kinder Morgan

Global X Russell 2000 Covered Call ETF

STAG Industrial

After 15 weeks and $1,500, the Dividend Harvesting Portfolio is generating $94.02 in estimated annual income and $7.83 in monthly estimated income.

Dividend Harvesting: Building The Portfolio Brick By Brick On $100 A Week, Week 15 Update

Altria's (MO) low-risk and oral tobacco offerings are gaining popularity. Moreover, high pricing for tobacco products is an upside.

Altria (MO) Gains on Low-Risk Tobacco Offerings, Strong Pricing

Vector Group

Solid pricing as well as growth in low-risk tobacco alternatives are favoring performance of tobacco players such as Philip Morris (PM), Altria (MO) and Vector Group (VGR).

3 Tobacco Stocks to Watch on Rising RRPs Demand & Pricing Gains

In recent years, Altria has suffered multiple blows - most notably the ill-timed acquisition of a minority stake in JUUL. Although the company has an impressive dividend streak, the size of the increases has been unimpressive in recent years.

The Trend Has Turned Up For Altria

Franklin Resources

Cincinnati Financial

Community Trust Bancorp

Con Ed

Federal Realty Investment Trust

Johnson & Johnson

Kimberly-Clark

McDonald's

Northwest Natural Gas

Old Republic International

Procter & Gamble

SJW Group

Telephone and Data Systems

United Bankshares

Universal Corp

V.F.

Walgreens

Drip Investing lists over 800 stocks that have annually increased dividends for 5 years or more. These 66 June stocks boosting dividends 40 years and more were parsed from 139 Champions posted 5/28/21. These 66 select dividend stocks ranged 0.70% to 6.86% in annual yield and ranged -8.12% to 30.72% in annual price target upside estimates per brokers sampled 6/10/21.

June's 40-Year-Plus Annual Dividend Boosters

News for Altria Stock (MO)